These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34144715)

  • 1. Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout.
    Djaafara BA; Whittaker C; Watson OJ; Verity R; Brazeau NF; Widyastuti ; Oktavia D; Adrian V; Salama N; Bhatia S; Nouvellet P; Sherrard-Smith E; Churcher TS; Surendra H; Lina RN; Ekawati LL; Lestari KD; Andrianto A; Thwaites G; Baird JK; Ghani AC; Elyazar IRF; Walker PGT
    BMC Med; 2021 Jun; 19(1):146. PubMed ID: 34144715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
    Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
    Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
    Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland.
    Shattock AJ; Le Rutte EA; Dünner RP; Sen S; Kelly SL; Chitnis N; Penny MA
    Epidemics; 2022 Mar; 38():100535. PubMed ID: 34923396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19.
    Pan J; Zhu W; Tian J; Liu Z; Xu A; Yao Y; Wang W
    Infect Dis Poverty; 2022 Mar; 11(1):36. PubMed ID: 35346382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021.
    Borchering RK; Viboud C; Howerton E; Smith CP; Truelove S; Runge MC; Reich NG; Contamin L; Levander J; Salerno J; van Panhuis W; Kinsey M; Tallaksen K; Obrecht RF; Asher L; Costello C; Kelbaugh M; Wilson S; Shin L; Gallagher ME; Mullany LC; Rainwater-Lovett K; Lemaitre JC; Dent J; Grantz KH; Kaminsky J; Lauer SA; Lee EC; Meredith HR; Perez-Saez J; Keegan LT; Karlen D; Chinazzi M; Davis JT; Mu K; Xiong X; Pastore Y Piontti A; Vespignani A; Srivastava A; Porebski P; Venkatramanan S; Adiga A; Lewis B; Klahn B; Outten J; Schlitt J; Corbett P; Telionis PA; Wang L; Peddireddy AS; Hurt B; Chen J; Vullikanti A; Marathe M; Healy JM; Slayton RB; Biggerstaff M; Johansson MA; Shea K; Lessler J
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):719-724. PubMed ID: 33988185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
    Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Delamater PL; Swann JL
    JAMA Netw Open; 2021 Jun; 4(6):e2110782. PubMed ID: 34061203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.
    Vilches TN; Abdollahi E; Cipriano LE; Haworth-Brockman M; Keynan Y; Sheffield H; Langley JM; Moghadas SM
    BMC Public Health; 2022 May; 22(1):1042. PubMed ID: 35614429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modelling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada.
    Aruffo E; Yuan P; Tan Y; Gatov E; Moyles I; Bélair J; Watmough J; Collier S; Arino J; Zhu H
    BMC Public Health; 2022 Jul; 22(1):1349. PubMed ID: 35841012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COVID-19 vaccination campaign in Switzerland and its impact on disease spread.
    Bekker-Nielsen Dunbar M; Held L
    Epidemics; 2024 Jun; 47():100745. PubMed ID: 38593727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-pharmaceutical interventions in containing COVID-19 pandemic after the roll-out of coronavirus vaccines: a systematic review.
    He X; Chen H; Zhu X; Gao W
    BMC Public Health; 2024 Jun; 24(1):1524. PubMed ID: 38844867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adjusting public health, travel, and social measures during the roll-out of COVID-19 vaccination: a modelling study.
    Leung K; Wu JT; Leung GM
    Lancet Public Health; 2021 Sep; 6(9):e674-e682. PubMed ID: 34388389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of early detection and vaccination strategy in COVID-19 eradication program in Jakarta, Indonesia.
    Aldila D; Samiadji BM; Simorangkir GM; Khosnaw SHA; Shahzad M
    BMC Res Notes; 2021 Apr; 14(1):132. PubMed ID: 33845887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study.
    Coudeville L; Jollivet O; Mahé C; Chaves S; Gomez GB
    PLoS One; 2021; 16(4):e0250797. PubMed ID: 33909687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Jentsch PC; Anand M; Bauch CT
    Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.
    Giordano G; Colaneri M; Di Filippo A; Blanchini F; Bolzern P; De Nicolao G; Sacchi P; Colaneri P; Bruno R
    Nat Med; 2021 Jun; 27(6):993-998. PubMed ID: 33864052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia.
    Bilgin GM; Munira SL; Lokuge K; Glass K
    Vaccine; 2024 Aug; 42(21):126163. PubMed ID: 39060201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study.
    Diarra M; Kebir A; Talla C; Barry A; Faye J; Louati D; Opatowski L; Diop M; ; White LJ; Loucoubar C; Miled SB
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35193893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.